FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← REGN · REGENERON PHARMACEUTICALS, INC.
DEFA14AThe Ballot

REGENERON PHARMACEUTICALS, INC. files DEFA14A

Filed Apr 24, 2026 · 2mo ago · Accession 0001308179-26-000341

Plain English

DEFA14A filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
REGENERON PHARMACEUTICALS, INC.
Ticker
REGN
CIK
872589
Form type
DEFA14A
Filing date
Apr 24, 2026
Report date
—
Document
a2026regeneronpharmaceutic.htm
Size
10.1 MB

More from REGN

8-KShareholder VoteJun 17, 20268-KResults of OperationsApr 29, 202610-QThe RecordApr 29, 2026DEF 14ADEFINITIVE PROXY STATEMENTApr 24, 20268-KResults of OperationsApr 8, 202610-KThe RecordFeb 4, 2026